JAK-TAP
JAK -TAP JAK Inhibitor Dose TAPering Strategy Study (JAK-TAP) Pathologie PR Établissement CHU de Brest Promoteur CHU de Toulouse Avancement…
DISRUPT
DISRUPT Effect of Controlling Environmental Risk Factors in Established RA (DISRUPT-estRA) Pathologie PR Établissement CHU de Brest Promoteur CHU de…
CLN-978-SJ-101
CLN-978-SJ-101 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren’s Disease Pathologie Maladie de…
CYTB323M12101B
CYTB323M12101B A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren’s Disease…
DAFFODIL
DAFFODIL Nipocalimab in Moderate to Severe Sjogren’s Disease Pathologie Maladie de Sjögren Établissement CHU de Brest Promoteur JANSSEN Avancement projet…